Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Nanoviricides News

    1,15 $ 0,00% +0,00 $
    In : 1,0734 € | 02:00:00 Uhr AMEX aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A2PSNF
    ISIN: US6300873022
    US-Symbol: NNVC
    Typ: Aktie

    Nanoviricides News

    09.08.22 - ACCESSWIRE
    NanoViricides Provides Additional Details on Its Rapid Monkeypox Drug Strategy
    SHELTON, CT / ACCESSWIRE / August 9, 2022 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in the development of highly effective antiviral ...
    04.08.22 - PR Newswire
    Thinking about buying stock in ChemoCentryx, Invivo Therapeutics, Greenlight Biosciences, Missfresh, or NanoViricides?
    Thinking about buying stock in ChemoCentryx, Invivo Therapeutics, Greenlight Biosciences, Missfresh, or NanoViricides? PR Newswire
    04.08.22 - ACCESSWIRE
    NanoViricides Reports That It Has Begun Drug Development to Combat Monkeypox Virus
    SHELTON, CT / ACCESSWIRE / August 4, 2022 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in the development of highly effective antiviral ...
    17.05.22 - ACCESSWIRE
    NanoViricides Has Filed Quarterly Report for Period Ending March 31, 2022 - Has Sufficient Cash, NV-CoV-2 Coronavirus Drug Candidate Progressing Further for Clinical Trials Application
    SHELTON, CT / ACCESSWIRE / May 17, 2022 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies ...
    13.10.21 - DGAP
    NanoViricides, Inc. Has Filed its Annual Report: Coronavirus Drug Program Rapidly Moving Towards Clinical Stage
    DGAP-News: NanoViricides, Inc. / Key word(s): Annual Report NanoViricides, Inc. Has Filed its Annual Report: Coronavirus Drug Program Rapidly Moving Towards Clinical Stage ...
    27.01.21 - DGAP
    NanoViricides, Inc.: Broad-Spectrum Direct Antiviral Nanomedicine Should Remain Effective Against COVID-19 Virus Variants, Says NanoViricides, Inc.'s President, Dr. Anil Diwan
    DGAP-News: NanoViricides, Inc. / Key word(s): Miscellaneous NanoViricides, Inc.: Broad-​Spectrum Direct Antiviral Nanomedicine Should Remain Effective Against COVID-19 Virus ...
    17.11.20 - DGAP
    NanoViricides Has Filed Quarterly Report for Period Ending September 30, 2020 - Has Sufficient Cash, Coronavirus Drug Development Progress
    DGAP-News: NanoViricides, Inc. / Key word(s): Quarter Results NanoViricides Has Filed Quarterly Report for Period Ending September 30, 2020 - Has Sufficient Cash, Coronavirus ...
    16.09.20 - DGAP
    NanoViricides Nominates a Novel Candidate for Advancing Into Clinical Trials for Treatment of COVID-19
    DGAP-News: NanoViricides, Inc. / Key word(s): Miscellaneous NanoViricides Nominates a Novel Candidate for Advancing Into Clinical Trials for Treatment of COVID-19 16.09.2020 / ...
    02.09.20 - ACCESSWIRE
    NanoViricides to Present COVID-19 Drug Update at The LD 500 Virtual Conference
    SHELTON, CT / ACCESSWIRE / September 2, 2020 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company") a global leader in the development of highly effective antiviral ...
    21.07.20 - DGAP
    NanoViricides to Participate in Panel Discussion at the B. Riley FBR Virtual Infectious Disease Summit Today, July 21, 2020
    DGAP-News: NanoViricides, Inc. / Key word(s): Miscellaneous NanoViricides to Participate in Panel Discussion at the B. Riley FBR Virtual Infectious Disease Summit Today, July 21, ...
    13.07.20 - DGAP
    NanoViricides Closes On $11.5 Million Underwritten Public Offering of Common Stock
    DGAP-News: NanoViricides, Inc. / Key word(s): Miscellaneous NanoViricides Closes On $11.5 Million Underwritten Public Offering of Common Stock 13.07.2020 / 14:00 The issuer ...
    09.07.20 - DGAP
    NanoViricides, Inc. Prices $10.0 Million Underwritten Public Offering of Common Stock
    DGAP-News: NanoViricides, Inc. / Key word(s): Offer NanoViricides, Inc. Prices $10.0 Million Underwritten Public Offering of Common Stock 09.07.2020 / 12:15 The issuer is solely ...
    30.06.20 - DGAP
    NanoViricides Announces Addition to Russell Microcap(R) Index
    DGAP-News: NanoViricides, Inc. / Key word(s): Miscellaneous NanoViricides Announces Addition to Russell Microcap(R) Index 30.06.2020 / 12:15 The issuer is solely responsible ...
    20.05.20 - DGAP
    NanoViricides, Inc.: Strong Effectiveness of NanoViricides Drug Candidates Observed in an Animal Model of Infection by an ACE2-using Human Coronavirus
    DGAP-News: NanoViricides, Inc. / Key word(s): Miscellaneous NanoViricides, Inc.: Strong Effectiveness of NanoViricides Drug Candidates Observed in an Animal Model of Infection ...
    31.03.20 - Newsfile
    NanoViricides, Inc. Progress on COVID-19 Drug Encouraging
    The Company's Update on its Development of COVID-19 Drug Candidate is Promising
    16.03.20 - DGAP
    NanoViricides, Inc.: Coronavirus Drug Development Update from NanoViricides, Inc.
    DGAP-News: NanoViricides, Inc. / Key word(s): Miscellaneous NanoViricides, Inc.: Coronavirus Drug Development Update from NanoViricides, Inc. 16.03.2020 / 11:15 The issuer is ...
    16.03.20 - ACCESSWIRE
    Coronavirus Drug Development Update from NanoViricides, Inc.
    SHELTON, CT / ACCESSWIRE / March 16, 2020 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company") a leader in the development of highly effective antiviral therapies ...
    05.03.20 - Newsfile
    NanoViricides, Inc. Reports Discovery of Broad-Spectrum Virus-Binding Ligands; Expected to Counter COVID-19
    The Company has been working on a drug candidate to address the COVID-19 and has made significant progress in this regard
    24.02.20 - ACCESSWIRE
    NanoViricides Has Filed Quarterly Report for Period Ending December 31, 2019 - Has Sufficient Cash, HerpeCide(TM) Drug Candidate IND Application Development in Progress
    SHELTON, CT / ACCESSWIRE / February 24, 2020 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company") a global leader in the development of highly effective antiviral ...
    12.02.20 - ACCESSWIRE
    Dr. Mak Jawadekar Joins the Board of Directors of NanoViricides, Inc.
    SHELTON, CT / ACCESSWIRE / February 12, 2020 / NanoViricides, Inc. (NYSE Amer.: NNVC ) (the "Company"), a leader in developing novel nanomedicines to treat viral diseases, ...

    Newssuche

    Videos

    newspaper
    09:30 Uhr +53,66%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »